Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
-
Field
-
mission: to uncover how nutrient signaling pathways, particularly GATOR1-mTORC1, influence neurodevelopment and seizure formation in epilepsy and autism. Why Join Us? Work on cutting-edge projects exploring
-
Dysregulation of the complement system is increasingly recognised as a key driver of neuroinflammation and neurodegeneration in progressive CNS disorders, including multiple sclerosis and epilepsy
-
rare inherited childhood mitochondrial disease. It is typically caused by changes in a gene known as POLG, resulting in a severe epilepsy, developmental delay and liver failure. The epilepsy is very
-
during pathological conditions. 2. Neonatal seizures and epilepsy 3. GABAA receptor physiology. We approach these research areas with electrophysiological and imaging. The Postdoctoral researcher will be
-
-related disorder (STXBP1-RD). Dr. Stamberger and Dr. Schoonjans are adult and pediatric neurologist respectively with a clinical focus on epilepsy and research focus on rare genetic epilepsy and
-
neurodevelopmental syndrome, STXBP1-related disorder (STXBP1-RD). Dr. Stamberger and Dr. Schoonjans are adult and pediatric neurologist respectively with a clinical focus on epilepsy and research focus on rare genetic
-
on multiscale analysis of brain disorders with a focus on Parkinson’s and Alzheimer’s disease, and epilepsy by combining experimental and computational approaches. For a collaborative project within the Institute
-
project at the CNNP Lab . The aim of ACORN is to understand the role of biological rhythms (chronobiology) in epilepsy and develop time-adaptive therapies. This project is funded by UKRI and is a
-
. Building on this work, we seek to harness the power of this new tool to optimize its therapeutic use for a wide variety of conditions including epilepsy, neuropsychiatric disease, movement disorders, chronic
-
Job description PhD position in computational neuroscience - Deep reinforcement learning closed-loop control for the treatment of epilepsy As part of the highly prestigious ERC Starting Grant